Targeting innate immunity for neurodegenerative disorders of the central nervous system

Katrin I. Andreasson, Adam D. Bachstetter, Marco Colonna, Florent Ginhoux, Clive Holmes, Bruce Lamb, Gary Landreth, Daniel C. Lee, Donovan Low, Marina A. Lynch, Alon Monsonego, M. Kerry O'Banion, Milos Pekny, Till Puschmann, Niva Russek-Blum, Leslie A. Sandusky, Maj Linda B Selenica, Kazuyuki Takata, Jessica Teeling, Terrence TownLinda J. Van Eldik

Research output: Contribution to journalReview article

53 Citations (Scopus)

Abstract

Neuroinflammation is critically involved in numerous neurodegenerative diseases, and key signaling steps of innate immune activation hence represent promising therapeutic targets. This mini review series originated from the 4th Venusberg Meeting on Neuroinflammation held in Bonn, Germany, 7–9th May 2015, presenting updates on innate immunity in acute brain injury and chronic neurodegenerative disorders, such as traumatic brain injury and Alzheimer disease, on the role of astrocytes and microglia, as well as technical developments that may help elucidate neuroinflammatory mechanisms and establish clinical relevance. In this meeting report, a brief overview of physiological and pathological microglia morphology is followed by a synopsis on PGE2 receptors, insights into the role of arginine metabolism and further relevant aspects of neuroinflammation in various clinical settings, and concluded by a presentation of technical challenges and solutions when working with microglia and astrocyte cultures. Microglial ontogeny and induced pluripotent stem cell-derived microglia, advances of TREM2 signaling, and the cytokine paradox in Alzheimer's disease are further contributions to this article. (Figure presented.) Neuroinflammation is critically involved in numerous neurodegenerative diseases, and key signaling steps of innate immune activation hence represent promising therapeutic targets. This mini review series originated from the 4th Venusberg Meeting on Neuroinflammation held in Bonn, Germany, 7–9th May 2015, presenting updates on innate immunity in acute brain injury and chronic neurodegenerative disorders, such as traumatic brain injury and Alzheimer's disease, on the role of astrocytes and microglia, as well as technical developments that may help elucidate neuroinflammatory mechanisms and establish clinical relevance. In this meeting report, a brief overview on physiological and pathological microglia morphology is followed by a synopsis on PGE2 receptors, insights into the role of arginine metabolism and further relevant aspects of neuroinflammation in various clinical settings, and concluded by a presentation of technical challenges and solutions when working with microglia cultures. Microglial ontogeny and induced pluripotent stem cell-derived microglia, advances of TREM2 signaling, and the cytokine paradox in Alzheimer's disease are further contributions to this article.

Original languageEnglish (US)
Pages (from-to)653-693
Number of pages41
JournalJournal of Neurochemistry
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Fingerprint

Microglia
Neurology
Innate Immunity
Neurodegenerative Diseases
Central Nervous System
Brain
Alzheimer Disease
Prostaglandin E Receptors
Astrocytes
Neurodegenerative diseases
Induced Pluripotent Stem Cells
Brain Diseases
Stem cells
Cell culture
Metabolism
Brain Injuries
Germany
Arginine
Chemical activation
Cytokines

Keywords

  • Alzheimer disease
  • blood–brain barrier
  • innate immunity
  • macrophage
  • non-steroidal anti-inflammatory drugs (NSAIDs)
  • Venusberg Neuroinflammation Meeting Bonn 2015

ASJC Scopus subject areas

  • Biochemistry
  • Medicine(all)
  • Cellular and Molecular Neuroscience

Cite this

Andreasson, K. I., Bachstetter, A. D., Colonna, M., Ginhoux, F., Holmes, C., Lamb, B., ... Van Eldik, L. J. (2016). Targeting innate immunity for neurodegenerative disorders of the central nervous system. Journal of Neurochemistry, 653-693. https://doi.org/10.1111/jnc.13667

Targeting innate immunity for neurodegenerative disorders of the central nervous system. / Andreasson, Katrin I.; Bachstetter, Adam D.; Colonna, Marco; Ginhoux, Florent; Holmes, Clive; Lamb, Bruce; Landreth, Gary; Lee, Daniel C.; Low, Donovan; Lynch, Marina A.; Monsonego, Alon; O'Banion, M. Kerry; Pekny, Milos; Puschmann, Till; Russek-Blum, Niva; Sandusky, Leslie A.; Selenica, Maj Linda B; Takata, Kazuyuki; Teeling, Jessica; Town, Terrence; Van Eldik, Linda J.

In: Journal of Neurochemistry, 01.09.2016, p. 653-693.

Research output: Contribution to journalReview article

Andreasson, KI, Bachstetter, AD, Colonna, M, Ginhoux, F, Holmes, C, Lamb, B, Landreth, G, Lee, DC, Low, D, Lynch, MA, Monsonego, A, O'Banion, MK, Pekny, M, Puschmann, T, Russek-Blum, N, Sandusky, LA, Selenica, MLB, Takata, K, Teeling, J, Town, T & Van Eldik, LJ 2016, 'Targeting innate immunity for neurodegenerative disorders of the central nervous system', Journal of Neurochemistry, pp. 653-693. https://doi.org/10.1111/jnc.13667
Andreasson, Katrin I. ; Bachstetter, Adam D. ; Colonna, Marco ; Ginhoux, Florent ; Holmes, Clive ; Lamb, Bruce ; Landreth, Gary ; Lee, Daniel C. ; Low, Donovan ; Lynch, Marina A. ; Monsonego, Alon ; O'Banion, M. Kerry ; Pekny, Milos ; Puschmann, Till ; Russek-Blum, Niva ; Sandusky, Leslie A. ; Selenica, Maj Linda B ; Takata, Kazuyuki ; Teeling, Jessica ; Town, Terrence ; Van Eldik, Linda J. / Targeting innate immunity for neurodegenerative disorders of the central nervous system. In: Journal of Neurochemistry. 2016 ; pp. 653-693.
@article{d7d7921ea3a7490787dd7e2cb5db6ec4,
title = "Targeting innate immunity for neurodegenerative disorders of the central nervous system",
abstract = "Neuroinflammation is critically involved in numerous neurodegenerative diseases, and key signaling steps of innate immune activation hence represent promising therapeutic targets. This mini review series originated from the 4th Venusberg Meeting on Neuroinflammation held in Bonn, Germany, 7–9th May 2015, presenting updates on innate immunity in acute brain injury and chronic neurodegenerative disorders, such as traumatic brain injury and Alzheimer disease, on the role of astrocytes and microglia, as well as technical developments that may help elucidate neuroinflammatory mechanisms and establish clinical relevance. In this meeting report, a brief overview of physiological and pathological microglia morphology is followed by a synopsis on PGE2 receptors, insights into the role of arginine metabolism and further relevant aspects of neuroinflammation in various clinical settings, and concluded by a presentation of technical challenges and solutions when working with microglia and astrocyte cultures. Microglial ontogeny and induced pluripotent stem cell-derived microglia, advances of TREM2 signaling, and the cytokine paradox in Alzheimer's disease are further contributions to this article. (Figure presented.) Neuroinflammation is critically involved in numerous neurodegenerative diseases, and key signaling steps of innate immune activation hence represent promising therapeutic targets. This mini review series originated from the 4th Venusberg Meeting on Neuroinflammation held in Bonn, Germany, 7–9th May 2015, presenting updates on innate immunity in acute brain injury and chronic neurodegenerative disorders, such as traumatic brain injury and Alzheimer's disease, on the role of astrocytes and microglia, as well as technical developments that may help elucidate neuroinflammatory mechanisms and establish clinical relevance. In this meeting report, a brief overview on physiological and pathological microglia morphology is followed by a synopsis on PGE2 receptors, insights into the role of arginine metabolism and further relevant aspects of neuroinflammation in various clinical settings, and concluded by a presentation of technical challenges and solutions when working with microglia cultures. Microglial ontogeny and induced pluripotent stem cell-derived microglia, advances of TREM2 signaling, and the cytokine paradox in Alzheimer's disease are further contributions to this article.",
keywords = "Alzheimer disease, blood–brain barrier, innate immunity, macrophage, non-steroidal anti-inflammatory drugs (NSAIDs), Venusberg Neuroinflammation Meeting Bonn 2015",
author = "Andreasson, {Katrin I.} and Bachstetter, {Adam D.} and Marco Colonna and Florent Ginhoux and Clive Holmes and Bruce Lamb and Gary Landreth and Lee, {Daniel C.} and Donovan Low and Lynch, {Marina A.} and Alon Monsonego and O'Banion, {M. Kerry} and Milos Pekny and Till Puschmann and Niva Russek-Blum and Sandusky, {Leslie A.} and Selenica, {Maj Linda B} and Kazuyuki Takata and Jessica Teeling and Terrence Town and {Van Eldik}, {Linda J.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/jnc.13667",
language = "English (US)",
pages = "653--693",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Targeting innate immunity for neurodegenerative disorders of the central nervous system

AU - Andreasson, Katrin I.

AU - Bachstetter, Adam D.

AU - Colonna, Marco

AU - Ginhoux, Florent

AU - Holmes, Clive

AU - Lamb, Bruce

AU - Landreth, Gary

AU - Lee, Daniel C.

AU - Low, Donovan

AU - Lynch, Marina A.

AU - Monsonego, Alon

AU - O'Banion, M. Kerry

AU - Pekny, Milos

AU - Puschmann, Till

AU - Russek-Blum, Niva

AU - Sandusky, Leslie A.

AU - Selenica, Maj Linda B

AU - Takata, Kazuyuki

AU - Teeling, Jessica

AU - Town, Terrence

AU - Van Eldik, Linda J.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Neuroinflammation is critically involved in numerous neurodegenerative diseases, and key signaling steps of innate immune activation hence represent promising therapeutic targets. This mini review series originated from the 4th Venusberg Meeting on Neuroinflammation held in Bonn, Germany, 7–9th May 2015, presenting updates on innate immunity in acute brain injury and chronic neurodegenerative disorders, such as traumatic brain injury and Alzheimer disease, on the role of astrocytes and microglia, as well as technical developments that may help elucidate neuroinflammatory mechanisms and establish clinical relevance. In this meeting report, a brief overview of physiological and pathological microglia morphology is followed by a synopsis on PGE2 receptors, insights into the role of arginine metabolism and further relevant aspects of neuroinflammation in various clinical settings, and concluded by a presentation of technical challenges and solutions when working with microglia and astrocyte cultures. Microglial ontogeny and induced pluripotent stem cell-derived microglia, advances of TREM2 signaling, and the cytokine paradox in Alzheimer's disease are further contributions to this article. (Figure presented.) Neuroinflammation is critically involved in numerous neurodegenerative diseases, and key signaling steps of innate immune activation hence represent promising therapeutic targets. This mini review series originated from the 4th Venusberg Meeting on Neuroinflammation held in Bonn, Germany, 7–9th May 2015, presenting updates on innate immunity in acute brain injury and chronic neurodegenerative disorders, such as traumatic brain injury and Alzheimer's disease, on the role of astrocytes and microglia, as well as technical developments that may help elucidate neuroinflammatory mechanisms and establish clinical relevance. In this meeting report, a brief overview on physiological and pathological microglia morphology is followed by a synopsis on PGE2 receptors, insights into the role of arginine metabolism and further relevant aspects of neuroinflammation in various clinical settings, and concluded by a presentation of technical challenges and solutions when working with microglia cultures. Microglial ontogeny and induced pluripotent stem cell-derived microglia, advances of TREM2 signaling, and the cytokine paradox in Alzheimer's disease are further contributions to this article.

AB - Neuroinflammation is critically involved in numerous neurodegenerative diseases, and key signaling steps of innate immune activation hence represent promising therapeutic targets. This mini review series originated from the 4th Venusberg Meeting on Neuroinflammation held in Bonn, Germany, 7–9th May 2015, presenting updates on innate immunity in acute brain injury and chronic neurodegenerative disorders, such as traumatic brain injury and Alzheimer disease, on the role of astrocytes and microglia, as well as technical developments that may help elucidate neuroinflammatory mechanisms and establish clinical relevance. In this meeting report, a brief overview of physiological and pathological microglia morphology is followed by a synopsis on PGE2 receptors, insights into the role of arginine metabolism and further relevant aspects of neuroinflammation in various clinical settings, and concluded by a presentation of technical challenges and solutions when working with microglia and astrocyte cultures. Microglial ontogeny and induced pluripotent stem cell-derived microglia, advances of TREM2 signaling, and the cytokine paradox in Alzheimer's disease are further contributions to this article. (Figure presented.) Neuroinflammation is critically involved in numerous neurodegenerative diseases, and key signaling steps of innate immune activation hence represent promising therapeutic targets. This mini review series originated from the 4th Venusberg Meeting on Neuroinflammation held in Bonn, Germany, 7–9th May 2015, presenting updates on innate immunity in acute brain injury and chronic neurodegenerative disorders, such as traumatic brain injury and Alzheimer's disease, on the role of astrocytes and microglia, as well as technical developments that may help elucidate neuroinflammatory mechanisms and establish clinical relevance. In this meeting report, a brief overview on physiological and pathological microglia morphology is followed by a synopsis on PGE2 receptors, insights into the role of arginine metabolism and further relevant aspects of neuroinflammation in various clinical settings, and concluded by a presentation of technical challenges and solutions when working with microglia cultures. Microglial ontogeny and induced pluripotent stem cell-derived microglia, advances of TREM2 signaling, and the cytokine paradox in Alzheimer's disease are further contributions to this article.

KW - Alzheimer disease

KW - blood–brain barrier

KW - innate immunity

KW - macrophage

KW - non-steroidal anti-inflammatory drugs (NSAIDs)

KW - Venusberg Neuroinflammation Meeting Bonn 2015

UR - http://www.scopus.com/inward/record.url?scp=84983611720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983611720&partnerID=8YFLogxK

U2 - 10.1111/jnc.13667

DO - 10.1111/jnc.13667

M3 - Review article

C2 - 27248001

AN - SCOPUS:84983611720

SP - 653

EP - 693

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

ER -